ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Abstract Text:

Subburaman Mohan,Garrett R Thompson,Yousef G Amaar,Gary Hathaway,Harald Tschesche,David J Baylink,

IGF binding protein-5 (BP-5) is an important bone formation regulator. Therefore, elucidation of the identity of IGF binding protein-5 (BP-5) protease produced by osteoblasts is important for our understanding of the molecular pathways that control the action of BP-5. In this regard, BP-5 protease purified by various chromatographic steps from a conditioned medium of U2 human osteosarcoma cells migrated as a single major band, which comigrated with the protease activity in native PAGE and yielded multiple bands in SDS-PAGE under reducing conditions. N-Terminal sequencing of these bands revealed that three of the bands yielded amino acid sequences that were identical to that of alpha2 macroglobulin (alpha2M). Although alpha2M was produced by human osteoblasts (OBs), it was not found to be a BP-5 protease. Because alpha2M had been shown to complex with ADAM proteases and because ADAM-12 was found to cleave BP-3 and BP-5, we evaluated if one of the members of ADAM family was the BP-5 protease. On the basis of the findings that (1) purified preparations of BP-5 protease from U2 cell CM contained ADAM-9, (2) ADAM-9 is produced and secreted in high abundance by various human OB cell types, (3) purified ADAM-9 cleaved BP-5 effectively while it did not cleave other IGFBPs or did so with less potency, and (4) purified ADAM-9 bound to alpha2M, we conclude that ADAM-9 is a BP-5 protease produced by human OBs.

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Publishing Authors By Initials

S Mohan,GR Thompson,YG Amaar,G Hathaway,H Tschesche,DJ Baylink,

For similar proteins: blood proteins: acute-phase proteins: alpha-macroglobulins research abstracts see: proteins: blood proteins: acute-phase proteins: alpha-macroglobulins research

PUBMED ID PMID:

MEDLINE DATE:

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Biochemistry

VOLUME: 41

Page Numbers: 15394-403

Journal Abbreviation: Biochemistry

ISSN: 0006-2960

DAY: 24

MONTH: Dec

YEAR: 2002

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370623

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Keywords Mesh Terms:

KEYWORDS: alpha-Macroglobulins

MESH TERMS: chemistry

Chemical & Substance for Abstract: ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Information

Substance Name: Metalloendopeptidases

Registry Number: EC 3.4.24.-

Grant and Affiliation Information for ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.

AFFILIATION: Musculoskeletal Diseases Center, Jerry L. Pettis VA Medical Center, 11201 Benton Street, Loma Linda, California 92357, USA. mohans@lom.med.va.gov

Country: United States

AGENCY: United States NIAMS

GRANT: AR31062

ACRONYM: AR

MEDLINETA: Biochemistry

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts Related Publications

• ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.
• Bone-derived factors active on bone cells.
• Bovine skeletal growth factor stimulates protein phosphorylation of chicken bone cells in vitro.
• Characterization of cells isolated and cultured from human bone.
• Chemical and biological characterization of low-molecular-weight human skeletal growth factor.
• Effect of bone matrix-derived growth factors on skull and tibia in the growing rat.
• Human skeletal growth factor stimulates collagen synthesis and inhibits proliferation in a clonal osteoblast cell line (MC3T3-E1).
• Human skeletal growth factor: characterization of the mitogenic effect on bone cells in vitro.
• In vitro metabolism of 25-hydroxyvitamin D3 by isolated rat kidney cells.
• Isolation and purification of a low-molecular-weight skeletal growth factor from human bones.
• Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II.
• Purification of a skeletal growth factor from human bone.
• Purification of bovine skeletal growth factor.
• Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat.
• Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice.
• Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells.
• Skeletal growth factor is produced by human osteoblast-like cells in culture.
• The diagnosis of osteoporosis.
• The renal metabolism of 25-hydroxyvitamin D3 in the rat: regulation by 1,25-dihydroxyvitamin D3.
• Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro.